EUVIMEDEUVIMED entdecken
Crossref

Molecular imaging reveals the heterogeneous progression of tumor cells and tumor stroma: a practice of FDG PET and FAPI PET in diagnosing PSMA-negative bone metastases of progressive prostate cancer

Lizhi Zhu

American Journal of Nuclear Medicine and Molecular Imaging · 2024

DOI: 10.62347/hvlf3619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Lizhi Zhu. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhu, L. (2024). Molecular imaging reveals the heterogeneous progression of tumor cells and tumor stroma: a practice of FDG PET and FAPI PET in diagnosing PSMA-negative bone metastases of progressive prostate cancer. American Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.62347/hvlf3619

Vancouver

Zhu L. Molecular imaging reveals the heterogeneous progression of tumor cells and tumor stroma: a practice of FDG PET and FAPI PET in diagnosing PSMA-negative bone metastases of progressive prostate cancer. American Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.62347/hvlf3619

BibTeX
@article{Zhu2024,
  author = {Zhu, Lizhi},
  title = {Molecular imaging reveals the heterogeneous progression of tumor cells and tumor stroma: a practice of FDG PET and FAPI PET in diagnosing PSMA-negative bone metastases of progressive prostate cancer},
  journal = {American Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  doi = {10.62347/hvlf3619}
}
Kostenlos starten →